After being induced, iPSC should be tested for their proficiency as an embryonic stem cell. This presentation provide a tool of one of the approaches used.
This document analyzes RNA-seq data from 16 human tissues and 5 cell lines to investigate whether genes typically express multiple isoforms at similar levels or have a single dominant transcript. The analysis found that:
1) For around 79% of genes, one isoform is expressed at least twice as strongly as the next highest isoform.
2) The major transcript of a gene tends to be consistently highly expressed across different tissues, though some switches between dominant transcripts were observed.
3) Around 85% of all mRNA comes from these dominant transcripts. This suggests that despite transcriptome complexity, the traditional view of one gene producing one protein may be closer to the truth than previously believed.
Single-cell RNA sequencing workshop given at the Ottawa Hospital Research Institute in 2018. Note that slides contain animations that won't be viewed in the slidehsare
Resolving transcriptional dynamics of the epithelial-mesenchymal transition u...David Cook
This document summarizes a presentation on resolving transcriptional dynamics during the epithelial-mesenchymal transition (EMT) using single-cell RNA sequencing. The presentation discusses using single-cell RNA sequencing to analyze over 10,000 cells undergoing a TGFB1-induced EMT over seven days. Analysis identified 1,777 differentially expressed genes and transcriptional trajectories throughout EMT. ATAC-seq was used to identify 115 transcription factor motifs with changing accessibility, including putative drivers of EMT changes like NFKB1, RELA, and SNAI2. Next steps proposed validating patterns, assessing transcription factor importance, and exploring generalizability across other EMT contexts.
Introduction
Transcriptome analysis
Goal of functional genomics
Why we need functional genomics
Technique
1. At DNA level
2.At RNA level
3. At protein level
4. loss of function
5. functional genomic and bioinformatics
Application
Latest research and reviews
Websites of functional genomics
Conclusions
Reference
Comparative genomics is the study of genome structure and function across species. Sequencing entire genomes is non-optimal due to vast numbers of species and large genome sizes, and individuals within a species have genetically distinct genomes. Comparative genomics addresses these issues using approaches like gene prediction algorithms that use features of protein-coding regions and tools that find putative genes or syntenic regions between genomes.
Bioinformatics uses techniques from applied mathematics, computer science, and statistics to understand and organize biological information on a large scale, especially regarding molecules like DNA, RNA, and proteins. Functional genomics uses high-throughput methods and bioinformatics to describe gene and protein functions and interactions at a genome-wide level. Key tools for functional genomics include sequence-based tools, microarray-based tools, and Gene Ontology for organizing gene function information. A systems biology approach integrates vast amounts of correlative genomic and proteomic data to help understand complex human diseases.
Genomics is a discipline in genetics that applies recombinant DNA, DNA sequencing methods, and bioinformatics to sequence, assemble and analyze the function and structure of genomes
This document analyzes RNA-seq data from 16 human tissues and 5 cell lines to investigate whether genes typically express multiple isoforms at similar levels or have a single dominant transcript. The analysis found that:
1) For around 79% of genes, one isoform is expressed at least twice as strongly as the next highest isoform.
2) The major transcript of a gene tends to be consistently highly expressed across different tissues, though some switches between dominant transcripts were observed.
3) Around 85% of all mRNA comes from these dominant transcripts. This suggests that despite transcriptome complexity, the traditional view of one gene producing one protein may be closer to the truth than previously believed.
Single-cell RNA sequencing workshop given at the Ottawa Hospital Research Institute in 2018. Note that slides contain animations that won't be viewed in the slidehsare
Resolving transcriptional dynamics of the epithelial-mesenchymal transition u...David Cook
This document summarizes a presentation on resolving transcriptional dynamics during the epithelial-mesenchymal transition (EMT) using single-cell RNA sequencing. The presentation discusses using single-cell RNA sequencing to analyze over 10,000 cells undergoing a TGFB1-induced EMT over seven days. Analysis identified 1,777 differentially expressed genes and transcriptional trajectories throughout EMT. ATAC-seq was used to identify 115 transcription factor motifs with changing accessibility, including putative drivers of EMT changes like NFKB1, RELA, and SNAI2. Next steps proposed validating patterns, assessing transcription factor importance, and exploring generalizability across other EMT contexts.
Introduction
Transcriptome analysis
Goal of functional genomics
Why we need functional genomics
Technique
1. At DNA level
2.At RNA level
3. At protein level
4. loss of function
5. functional genomic and bioinformatics
Application
Latest research and reviews
Websites of functional genomics
Conclusions
Reference
Comparative genomics is the study of genome structure and function across species. Sequencing entire genomes is non-optimal due to vast numbers of species and large genome sizes, and individuals within a species have genetically distinct genomes. Comparative genomics addresses these issues using approaches like gene prediction algorithms that use features of protein-coding regions and tools that find putative genes or syntenic regions between genomes.
Bioinformatics uses techniques from applied mathematics, computer science, and statistics to understand and organize biological information on a large scale, especially regarding molecules like DNA, RNA, and proteins. Functional genomics uses high-throughput methods and bioinformatics to describe gene and protein functions and interactions at a genome-wide level. Key tools for functional genomics include sequence-based tools, microarray-based tools, and Gene Ontology for organizing gene function information. A systems biology approach integrates vast amounts of correlative genomic and proteomic data to help understand complex human diseases.
Genomics is a discipline in genetics that applies recombinant DNA, DNA sequencing methods, and bioinformatics to sequence, assemble and analyze the function and structure of genomes
This document discusses structural genomics and its goals of determining the 3D structures of large numbers of gene products to identify novel protein folds and sequences. It describes methods for structural determination including de novo and modeling based approaches. Specific proteome projects on Thermotoga maritima and Mycobacterium tuberculosis are mentioned. The objectives of structural genomics are outlined as providing structural information to aid research, experimental design, identification of new structure-based medicines, and development of better therapeutics.
This document summarizes information from a student's assignment on plant genome sequencing techniques. It discusses early phenotypic selection methods and their limitations. It then summarizes different sequencing strategies used for important crop plants like rice, poplar, and Arabidopsis. These include BAC-by-BAC, whole genome shotgun, and various next-generation sequencing platforms. The document also summarizes applications of sequencing including identifying genes related to rice yield and flowering time and using sequencing to improve potato and maize varieties.
The document discusses the European Bioinformatics Institute (EBI) and its work in building an archive of public gene expression data through its ArrayExpress database. It outlines EBI's transition from archiving microarray data to RNA-seq data and describes its Gene Expression Atlas, which provides baseline expression data across many RNA-seq experiments to allow users to search for gene and condition-specific expression. The Gene Expression Atlas is still in development and plans to further integrate proteomics data, include genome browser views, and aggregate more comparable experiments.
Comparative genomics involves comparing genomes to discover similarities and differences. It can provide insights into evolutionary relationships, help predict gene function, and aid in drug discovery. The first step is often aligning genome sequences using tools like BLAST or MUMmer. Genomes can then be compared at various levels, such as overall nucleotide statistics, genome structure, and coding/non-coding regions. Comparing gene and protein content across genomes helps predict functions. Conserved genomic features across species also aid prediction. Insights into genome evolution come from studying molecular events like inversions and duplications. Comparative genomics has impacted phylogenetics and drug target identification.
Genomics is the study of genomes through mapping, sequencing, and analysis. It involves sequencing entire genomes and analyzing gene function on a genome-wide scale. There are three main areas of genomics: structural genomics focuses on sequencing and mapping genomes; functional genomics examines gene expression and protein interactions; and comparative genomics compares genomic features between organisms to study evolution and biology. Techniques like DNA sequencing, microarrays, and bioinformatics are used to efficiently analyze entire genomes and understand how the structure and function of genomes relate to biological processes.
This document describes a microfluidic bioreactor system developed to provide controlled spatial and temporal concentration gradients of multiple molecular factors to 3D cultures of human pluripotent stem cells. The bioreactor contains rows of microwells connected by microchannels that generate stable concentration gradients when different factors are flowed through the lateral channels. Human embryonic and induced pluripotent stem cells were cultured as embryoid bodies in the bioreactor and exposed to gradients of mesoderm-inducing morphogens. Gene expression analysis showed the system could evaluate the initiation of mesodermal induction in a controlled manner. The bioreactor aims to provide a more in vivo-like model for studying stem cell development and differentiation.
ArrayGen Technologies Pvt Ltd is a Genomics service provider company with the wide array of expertise in Genomics algorithm development, next-generation sequencing(NGS), microarray and Bioinformatics services. Also, involved in various services in both industry and academia.
The document discusses genomics and comparative genomics. It defines genomics as the study of genomes and notes that comparative genomics compares two or more genomes to discover similarities and differences. Comparative genomics can provide insights into evolutionary biology, drug discovery, gene function prediction, and identification of genes and regulatory elements. The document outlines different levels of genome comparison including nucleotide statistics, genome structure at the DNA and gene levels, and describes various methods used in comparative genomic analyses.
The document discusses the human genome project, which aimed to sequence the entire human genome and identify all human genes. It provides background on the human genome, describing its size, number of genes, and chromosomes. It details the goals and milestones of the human genome project from 1986 to 2003. Vectors like yeast artificial chromosomes and bacterial artificial chromosomes were used to clone large fragments of DNA for sequencing.
This document discusses the collaboration between molecular medicine and bioinformatics. It defines bioinformatics as the science of storing, retrieving, and analyzing large amounts of biological data, cutting across biology, computer science, and mathematics. It gives examples of how bioinformatics can be applied in molecular medicine for studying pathogenicity, therapeutic targets, molecular diagnostics, and host-pathogen interactions. The document also outlines how bioinformatics supports molecular medicine through genome analysis, database and tool development, and describes some catalysts like genome sequencing that have expanded bioinformatics.
This document discusses DNA sequencing, including its steps and uses for the Human Genome Project, genetic counseling, and more. It also addresses ethical concerns around privacy and genetic manipulation. Finally, it outlines potential future applications such as understanding human development and curing diseases through continued discoveries related to how genes function.
This document summarizes a research article that presents the Network of Cancer Genes (NCG) database. NCG analyzes and stores data on over 730 cancer genes, including their duplicability, orthology, and network properties. It collects data on whether genes are duplicated in the human genome, when they first evolutionarily appeared, and their interactions in protein-protein interaction networks. NCG is the first database to analyze cancer genes from a systems-level perspective and integrate multiple types of genomic and protein interaction data. It aims to be continuously updated as more cancer gene data becomes available from projects like the Cancer Genome Project.
Structural genomics aims to sequence and map genomes. Genetic maps show relative gene locations based on recombination rates, while physical maps show direct DNA distances. Genetic maps have low resolution and may differ from physical distances. Physical maps use techniques like restriction mapping and sequencing to order DNA fragments. Sequencing entire genomes requires breaking DNA into small fragments that are then reassembled using overlap or genetic/physical maps. The human genome was first sequenced in 2000 using both map-based and whole genome shotgun approaches. Single nucleotide polymorphisms are also studied to compare individuals.
Tulane Workshop on Multi-omics integrationElia Brodsky
Pine Biotech held a workshop and discussion of the approaches that are being developed for the T-BioInfo platform. The approaches were presented by Julia Panov, a Ph.D. student from Haifa University and data scientist working at Pine Biotech. Her presentation covered some of the projects with preliminary results showing a promising method of integrating various omics data types and applying them to noisy datasets signal processing for target discovery and biomarkers. The workshop was held at the Flower Hall at Tulane University. This was the first presentation to over 40 people that gathered to discuss interesting applications of biomedical data analysis to healthcare and pharma. Dr. Yu-Ping Wang and Dr. Lars Gilbertson from the department of Biomedical Engineering also shared their perspective on this important topic.
http://pine-biotech.com/workshop-roundtable-discussion-tulane-pine-biotech/
The Human Genome Project (HGP) was a 13-year international project completed in 2003 that aimed to identify all the genes in human DNA and determine the sequence of the 3 billion base pairs that make up human DNA. Knowing this genetic information could enable personalized medicine by providing different treatments tailored to a patient's genes, replacing genes associated with genetic diseases, improving accuracy of paternity testing, and screening embryos for genetic diseases. However, some concerns exist that employers or insurance companies could discriminate based on genetic information, or that learning one's genetic risks could cause depression.
This document discusses proteomics and systems biology. It explains that systems biology analyzes relationships between elements in a biological system in response to genetic or environmental changes, with the goal of understanding the system. Proteomics aims to characterize proteins, including structure, function, interactions, and expression levels. Integrating omics data like genomics, proteomics and metabolomics can provide insights into biological processes and disease. Proteomics can also play roles in drug development by aiding biomarker discovery, target identification, and toxicity prediction.
This document discusses functional genomics and its approaches. It defines functional genomics as the worldwide experimental approach to access the function of genes by using information from structural genomics. The key functional genomics approaches discussed are transcriptomics, proteomics, metabolomics, interactomics, epigenetics, and nutrigenomics. Modern techniques discussed include expressed sequence tags (ESTs), serial analysis of gene expression (SAGE), and microarray analysis.
Nadia Pisanti - With the recent New Genome Sequencing Technologies, Medicine and Biology are witnessing a revolution where Computer Science and Data Analysis play a crucial role. In this talk, I will give an overview of perspectives and challenges in this field.
Refining Gene Ontology to Include Terms and Relationships Relevant to exRNA C...exrna
The document discusses efforts to standardize terminology related to extracellular vesicles (EVs) and exRNA-containing particles through developing new terms and relationships within the Gene Ontology (GO). It describes work with domain experts to propose additions to GO's Cellular Component branch to accurately describe and classify EVs and exRNA communications. The goal is to strike a balance between overgeneralizing and being too specific when defining terms in this emerging research area.
Single cell RNA-seq was performed on 18 mouse bone marrow dendritic cells. 982 genes were found to be differentially expressed between two cells, while the majority of genes showed similar expression levels. Future work will analyze the functions of differentially expressed genes to better understand heterogeneity between cells and potential roles in disease.
1) The document discusses a study analyzing the impact of gene length on detecting differentially expressed genes using RNA-seq technology.
2) The study will first test the reproducibility of RNA-seq and the effect of normalization. It will then compare different statistical tests for identifying differentially expressed genes.
3) Finally, the study will specifically test how gene length impacts the likelihood of a gene being identified as differentially expressed, as longer genes are easier to map with short reads.
This document discusses structural genomics and its goals of determining the 3D structures of large numbers of gene products to identify novel protein folds and sequences. It describes methods for structural determination including de novo and modeling based approaches. Specific proteome projects on Thermotoga maritima and Mycobacterium tuberculosis are mentioned. The objectives of structural genomics are outlined as providing structural information to aid research, experimental design, identification of new structure-based medicines, and development of better therapeutics.
This document summarizes information from a student's assignment on plant genome sequencing techniques. It discusses early phenotypic selection methods and their limitations. It then summarizes different sequencing strategies used for important crop plants like rice, poplar, and Arabidopsis. These include BAC-by-BAC, whole genome shotgun, and various next-generation sequencing platforms. The document also summarizes applications of sequencing including identifying genes related to rice yield and flowering time and using sequencing to improve potato and maize varieties.
The document discusses the European Bioinformatics Institute (EBI) and its work in building an archive of public gene expression data through its ArrayExpress database. It outlines EBI's transition from archiving microarray data to RNA-seq data and describes its Gene Expression Atlas, which provides baseline expression data across many RNA-seq experiments to allow users to search for gene and condition-specific expression. The Gene Expression Atlas is still in development and plans to further integrate proteomics data, include genome browser views, and aggregate more comparable experiments.
Comparative genomics involves comparing genomes to discover similarities and differences. It can provide insights into evolutionary relationships, help predict gene function, and aid in drug discovery. The first step is often aligning genome sequences using tools like BLAST or MUMmer. Genomes can then be compared at various levels, such as overall nucleotide statistics, genome structure, and coding/non-coding regions. Comparing gene and protein content across genomes helps predict functions. Conserved genomic features across species also aid prediction. Insights into genome evolution come from studying molecular events like inversions and duplications. Comparative genomics has impacted phylogenetics and drug target identification.
Genomics is the study of genomes through mapping, sequencing, and analysis. It involves sequencing entire genomes and analyzing gene function on a genome-wide scale. There are three main areas of genomics: structural genomics focuses on sequencing and mapping genomes; functional genomics examines gene expression and protein interactions; and comparative genomics compares genomic features between organisms to study evolution and biology. Techniques like DNA sequencing, microarrays, and bioinformatics are used to efficiently analyze entire genomes and understand how the structure and function of genomes relate to biological processes.
This document describes a microfluidic bioreactor system developed to provide controlled spatial and temporal concentration gradients of multiple molecular factors to 3D cultures of human pluripotent stem cells. The bioreactor contains rows of microwells connected by microchannels that generate stable concentration gradients when different factors are flowed through the lateral channels. Human embryonic and induced pluripotent stem cells were cultured as embryoid bodies in the bioreactor and exposed to gradients of mesoderm-inducing morphogens. Gene expression analysis showed the system could evaluate the initiation of mesodermal induction in a controlled manner. The bioreactor aims to provide a more in vivo-like model for studying stem cell development and differentiation.
ArrayGen Technologies Pvt Ltd is a Genomics service provider company with the wide array of expertise in Genomics algorithm development, next-generation sequencing(NGS), microarray and Bioinformatics services. Also, involved in various services in both industry and academia.
The document discusses genomics and comparative genomics. It defines genomics as the study of genomes and notes that comparative genomics compares two or more genomes to discover similarities and differences. Comparative genomics can provide insights into evolutionary biology, drug discovery, gene function prediction, and identification of genes and regulatory elements. The document outlines different levels of genome comparison including nucleotide statistics, genome structure at the DNA and gene levels, and describes various methods used in comparative genomic analyses.
The document discusses the human genome project, which aimed to sequence the entire human genome and identify all human genes. It provides background on the human genome, describing its size, number of genes, and chromosomes. It details the goals and milestones of the human genome project from 1986 to 2003. Vectors like yeast artificial chromosomes and bacterial artificial chromosomes were used to clone large fragments of DNA for sequencing.
This document discusses the collaboration between molecular medicine and bioinformatics. It defines bioinformatics as the science of storing, retrieving, and analyzing large amounts of biological data, cutting across biology, computer science, and mathematics. It gives examples of how bioinformatics can be applied in molecular medicine for studying pathogenicity, therapeutic targets, molecular diagnostics, and host-pathogen interactions. The document also outlines how bioinformatics supports molecular medicine through genome analysis, database and tool development, and describes some catalysts like genome sequencing that have expanded bioinformatics.
This document discusses DNA sequencing, including its steps and uses for the Human Genome Project, genetic counseling, and more. It also addresses ethical concerns around privacy and genetic manipulation. Finally, it outlines potential future applications such as understanding human development and curing diseases through continued discoveries related to how genes function.
This document summarizes a research article that presents the Network of Cancer Genes (NCG) database. NCG analyzes and stores data on over 730 cancer genes, including their duplicability, orthology, and network properties. It collects data on whether genes are duplicated in the human genome, when they first evolutionarily appeared, and their interactions in protein-protein interaction networks. NCG is the first database to analyze cancer genes from a systems-level perspective and integrate multiple types of genomic and protein interaction data. It aims to be continuously updated as more cancer gene data becomes available from projects like the Cancer Genome Project.
Structural genomics aims to sequence and map genomes. Genetic maps show relative gene locations based on recombination rates, while physical maps show direct DNA distances. Genetic maps have low resolution and may differ from physical distances. Physical maps use techniques like restriction mapping and sequencing to order DNA fragments. Sequencing entire genomes requires breaking DNA into small fragments that are then reassembled using overlap or genetic/physical maps. The human genome was first sequenced in 2000 using both map-based and whole genome shotgun approaches. Single nucleotide polymorphisms are also studied to compare individuals.
Tulane Workshop on Multi-omics integrationElia Brodsky
Pine Biotech held a workshop and discussion of the approaches that are being developed for the T-BioInfo platform. The approaches were presented by Julia Panov, a Ph.D. student from Haifa University and data scientist working at Pine Biotech. Her presentation covered some of the projects with preliminary results showing a promising method of integrating various omics data types and applying them to noisy datasets signal processing for target discovery and biomarkers. The workshop was held at the Flower Hall at Tulane University. This was the first presentation to over 40 people that gathered to discuss interesting applications of biomedical data analysis to healthcare and pharma. Dr. Yu-Ping Wang and Dr. Lars Gilbertson from the department of Biomedical Engineering also shared their perspective on this important topic.
http://pine-biotech.com/workshop-roundtable-discussion-tulane-pine-biotech/
The Human Genome Project (HGP) was a 13-year international project completed in 2003 that aimed to identify all the genes in human DNA and determine the sequence of the 3 billion base pairs that make up human DNA. Knowing this genetic information could enable personalized medicine by providing different treatments tailored to a patient's genes, replacing genes associated with genetic diseases, improving accuracy of paternity testing, and screening embryos for genetic diseases. However, some concerns exist that employers or insurance companies could discriminate based on genetic information, or that learning one's genetic risks could cause depression.
This document discusses proteomics and systems biology. It explains that systems biology analyzes relationships between elements in a biological system in response to genetic or environmental changes, with the goal of understanding the system. Proteomics aims to characterize proteins, including structure, function, interactions, and expression levels. Integrating omics data like genomics, proteomics and metabolomics can provide insights into biological processes and disease. Proteomics can also play roles in drug development by aiding biomarker discovery, target identification, and toxicity prediction.
This document discusses functional genomics and its approaches. It defines functional genomics as the worldwide experimental approach to access the function of genes by using information from structural genomics. The key functional genomics approaches discussed are transcriptomics, proteomics, metabolomics, interactomics, epigenetics, and nutrigenomics. Modern techniques discussed include expressed sequence tags (ESTs), serial analysis of gene expression (SAGE), and microarray analysis.
Nadia Pisanti - With the recent New Genome Sequencing Technologies, Medicine and Biology are witnessing a revolution where Computer Science and Data Analysis play a crucial role. In this talk, I will give an overview of perspectives and challenges in this field.
Refining Gene Ontology to Include Terms and Relationships Relevant to exRNA C...exrna
The document discusses efforts to standardize terminology related to extracellular vesicles (EVs) and exRNA-containing particles through developing new terms and relationships within the Gene Ontology (GO). It describes work with domain experts to propose additions to GO's Cellular Component branch to accurately describe and classify EVs and exRNA communications. The goal is to strike a balance between overgeneralizing and being too specific when defining terms in this emerging research area.
Single cell RNA-seq was performed on 18 mouse bone marrow dendritic cells. 982 genes were found to be differentially expressed between two cells, while the majority of genes showed similar expression levels. Future work will analyze the functions of differentially expressed genes to better understand heterogeneity between cells and potential roles in disease.
1) The document discusses a study analyzing the impact of gene length on detecting differentially expressed genes using RNA-seq technology.
2) The study will first test the reproducibility of RNA-seq and the effect of normalization. It will then compare different statistical tests for identifying differentially expressed genes.
3) Finally, the study will specifically test how gene length impacts the likelihood of a gene being identified as differentially expressed, as longer genes are easier to map with short reads.
Molecular techniques for pathology research - MDX .pdfsabyabby
This document discusses molecular techniques used in pathology research such as PCR, microarrays, next generation sequencing, immunohistochemistry, ELISA, and Western blotting. It provides details on each technique including the basic principles, applications in research, and examples of uses in studies of gene expression, cancer, bone disease, and growth retardation. The learning outcomes are to understand these techniques and their uses in basic and clinical research.
Maha W. Rizk is a senior-level researcher with over 10 years of experience in biotechnology and pharmaceuticals. She has expertise in oncology, inflammation, and neurological biomarkers as well as experience in drug discovery, preclinical studies, and clinical trials. Her technical skills include developing and validating cell-based assays, protein analysis, DNA/RNA extraction, and data analysis software. She currently works as a senior associate scientist at Amgen performing assays for oncology, inflammation, and neuroscience drug candidates.
description of functional genomics and structural genomics and the techniques involved in it and also decribing the models of forward genetics and techniques involved in it and reverse genetics and techniques involved in it
Current CV .
My objective is to obtain a rewarding and challenging research scientist position where my background and experience will contribute to the success of a growing company or research center.
Currently, I am a Senior Associate Scientist at Amgen Inc. and certified Molecular Biologist with the American Society of Clinical Pathology MB (ASCP). I have more than 10 years of experience in the biotechnology/ pharmaceutical industry. I am highly proficient in various lab techniques, technologies, and automation. I demonstrated consistent success in the execution of assay development and method validation activities supporting clinical stage programs within GCP and GLP regulated environments. I possess extensive experience in optimization and validation of drug potency assays (ELISA and cell based assays), protein purification and characterization, and DNA/RNA extraction and quantitation. I am a subject matter expertise in the areas of human and rodent cell lines propagation and tissue dis-aggregation. I have proven operational capabilities in the establishment of standard operating procedures to ensure our laboratory meets regulatory and business requirements.
I am a self-motivated professional who works effectively as an individual contributor or within a team matrix. As a quick learner, I can efficiently deliver results, easily adapt to changing environment and provide fresh ideas. My strengths include statistical analysis/guidance, report writing, and communication.
Thank you in advance for your consideration. Please feel free to call me at (805-990-6258), or by e-mail at (mahawally46@gmail.com) if you have questions or would like a list of references.
Sincerely,
Maha Rizk
Acroscell provides ready-to-use beating human induced pluripotent stem cells (iPSC)-derived cardiomyocytes. Generated from mature cells that have been genetically reprogramed to a pluripotent stem cell state, induced pluripotent stem cells (iPSCs) can be readily expanded and induced to specialize or differentiate into cardiomyocytes in vitro.
https://www.creative-bioarray.com/acroscell/ipsc-derived-cardiomyocytes.html
The discovery that somatic cells could be reprogrammed to a pluripotent state has profoundly altered the landscape in which stem cell research is conducted.
Induced Pluripotent Stem Cells (iPSCs) are a type pf pluripotent stem cell artificially derived, and often referred to as programmed, from adult somatic cells using the expression of certain genes in culture.
https://www.creative-bioarray.com/products/ipsc-reprogramming-kit-list-239.htm
Total RNA Discovery for RNA Biomarker Development WebinarQIAGEN
Precision medicine offers to transform patient care by targeting treatment to those with most to gain. To date the most significant advances have been at the level of DNA, for example, the use of somatic DNA alterations as diagnostic indicators of disease and for prediction of pharmacodynamic response. Development of RNA expression signatures as biomarkers has been more problematic. While RNA expression analysis has yielded valuable insights into the biological mechanisms of disease, RNA is a more unstable molecule than DNA, and more easily damaged or degraded during sample collection and isolation. In addition, RNA levels are inherently dynamic and gene expression signatures are extraordinarily complex. Recently, much progress has been made in identifying key changes in gene expression in cancer and other diseases, as well as identifying expression signatures in circulating nucleic acid that have the potential to be developed into diagnostic and prognostic indicators.
Now a day’s, pharma research is facing challenges in
deciphering molecular understanding of disease initiation,
progress and establishment as well as performance
assessment of drug molecule on such phases of disease
development. Emerging of next generation sequencing
bases molecular tools were found to be a key method for
creating genome wide genomics landscape of gene
mutations, gene expression and gene regulation events.
Although NGS is a powerful tool for molecular research but
same time it have its own technical challenges. Few major
challenges of NGS based pharmacogenomics is
summarized below
Discover new cases studies giving you unprecedented access to both the data and results of how RNA-Seq is being applied successfully from bench to bedside
Gain new insights into RNA-Seq for the study of toxicity, IO, host-viral interactions and more from companies such as BMS, Janssen, Pfizer, Merck, UCSC and Stanford
The document discusses various topics related to molecular profiling and personalized medicine. It describes first generation molecular profiling techniques like gene sequencing, microarrays, and PCR. It then covers next generation sequencing technologies like Roche 454, Illumina, and ABI SOLID. It also discusses second generation techniques for DNA and RNA profiling including exome sequencing, ChIP-seq, and RNA-seq. Finally, it briefly mentions third generation sequencing and epigenetic profiling.
Genetic screening of CRISPR edited human-derived induced pluripotent stem cells was conducted to create a model of Costello syndrome. CRISPR was used to induce mutations in the HRAS gene of iPSCs. Of 12 samples screened, 2 were found to have a heterozygous mutation and 1 had a homozygous mutation, supporting that CRISPR can be used for gene editing in iPSCs. The mutated iPSCs will be differentiated into cardiomyocytes to model cardiac abnormalities in Costello syndrome.
Developing a Rapid Clinical Sequencing System to Classify Meningioma: Meet th...QIAGEN
Meningioma’s display a broad spectrum of clinical, histological and cytogenetic features even within the same WHO grade often posing a challenge for classification and prognostic stratification. In this webinar, we will describe our experience of using targeted amplicon sequencing to develop rapid clinical sequencing system to identify and confirm the meningioma genotype in just two weeks. In addition the details of the three meningioma categories and the genes involved will be discussed.
Gene expression profile of the tumor microenvironment from 40 NSCLC FFPE and ...Thermo Fisher Scientific
The tumor microenvironment (TME) is the intersection between tumor cells and
surrounding non-transformed cells. It contains immune cells, signaling molecules,
stromal and extracellular matrix. Research has shown the TME is often associated
with tumor growth. However, the function and regulatory mechanism of each
constituent is still poorly understood. The presence of PD-L1 is a promising marker
to predict positive response for T cell checkpoint therapy. Current IHC methods to
measure PD-L1 are subjective and highly variable. A higher-throughput and
standardized method that can systematically measure gene expression of cells
present in the TME has emerged to be a more desirable solution.
We applied the OncomineTM Immune Response Research Assay to measure the
expression of 395 genes in non-small cell lung cancer (NSCLC) research samples
from 40 matched FFPE and fresh frozen sample types. This assay covers genes
involved in checkpoint pathway, T cell regulation, cytokine and interferon signaling
pathways, and markers of different tumor infiltrating lymphocyte (TIL) subsets, as
well as tumor markers. With an input requirement of 10 ng of total RNA, libraries
were generated, templated on the Ion ChefTM and sequenced on the Ion S5TM
System. Sequencing data was analyzed and mapped with Torrent Suite Software
and differential expression analysis was conducted with AffymetrixTM Transcriptome
Analysis Console.
This document discusses how normalization methods for gene expression measurements that assume equal cellular RNA content across experimental conditions can mask differences in total RNA yield per cell. The authors demonstrate that total RNA yield from Chinese Hamster Ovary (CHO) cells varies between experimental treatments and cell lines expressing recombinant proteins. They apply a normalization method using synthetic spike-in RNA standards added proportionally to cell number, which reveals differences in cellular RNA content and allows detection of global transcriptional amplification or repression. They use this method to assess gene expression in CHO cell lines of different sizes treated with cell cycle or mTOR inhibitors, or subjected to high osmolarity conditions. They find that a cell cycle inhibitor increases cell size and transcriptional amplification, an mTOR inhibitor causes
Similar to Standardization of human stem cell pluripotency using bioinformatics presentation 1 (20)
A Free 200-Page eBook ~ Brain and Mind Exercise.pptxOH TEIK BIN
(A Free eBook comprising 3 Sets of Presentation of a selection of Puzzles, Brain Teasers and Thinking Problems to exercise both the mind and the Right and Left Brain. To help keep the mind and brain fit and healthy. Good for both the young and old alike.
Answers are given for all the puzzles and problems.)
With Metta,
Bro. Oh Teik Bin 🙏🤓🤔🥰
CapTechTalks Webinar Slides June 2024 Donovan Wright.pptxCapitolTechU
Slides from a Capitol Technology University webinar held June 20, 2024. The webinar featured Dr. Donovan Wright, presenting on the Department of Defense Digital Transformation.
Gender and Mental Health - Counselling and Family Therapy Applications and In...PsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...TechSoup
Whether you're new to SEO or looking to refine your existing strategies, this webinar will provide you with actionable insights and practical tips to elevate your nonprofit's online presence.
A Visual Guide to 1 Samuel | A Tale of Two HeartsSteve Thomason
These slides walk through the story of 1 Samuel. Samuel is the last judge of Israel. The people reject God and want a king. Saul is anointed as the first king, but he is not a good king. David, the shepherd boy is anointed and Saul is envious of him. David shows honor while Saul continues to self destruct.
How to Manage Reception Report in Odoo 17Celine George
A business may deal with both sales and purchases occasionally. They buy things from vendors and then sell them to their customers. Such dealings can be confusing at times. Because multiple clients may inquire about the same product at the same time, after purchasing those products, customers must be assigned to them. Odoo has a tool called Reception Report that can be used to complete this assignment. By enabling this, a reception report comes automatically after confirming a receipt, from which we can assign products to orders.
Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...EduSkills OECD
Andreas Schleicher, Director of Education and Skills at the OECD presents at the launch of PISA 2022 Volume III - Creative Minds, Creative Schools on 18 June 2024.
Standardization of human stem cell pluripotency using bioinformatics presentation 1
1. Standardization of human stem cell
pluripotency using bioinformatics
A review paper in stem cell research & therapy
Bader Al Alwan
2. In this review
Technologies currently being used to produce standardized, high-quality
stem cells
Assays for pluripotency using bioinformatics and gene expression profiling
A number of approaches that promise to improve unbiased prediction of
utility of iPSCs and ESCs
3. Introduction
Four TF (Oct4, KLf4, Sox2 and c-Myc) were sufficient to convert adult cells
into iPSCs; Takahashi and Yamanaka.
Then, a number of studies emerged illustrating the potency of these cells
to differentiate into various progenitors.
The generation of iPSCs raised:
- Epigenetic and gene expression changes
- Highly variable population of reprogramming states
- Can generate inefficient and highly variable yield observed during iPSCs
generation.
How iPSCs behave in functional assays compared to ESCs, and how their
quality and uniformity been efficiently tested?
4. Bioinformatic assays for pluripotency
There has been a much progress in developing genome-wide assays and
associated bioinformatic methods
The global analysis of the epigenome
Analysis of various non-coding RNAs
5. Gene Expression Profiling
DNA microarray was the first method of global molecular analysis used
PluriTest, an algorithm that construct bioinformatic models for assessing the
quality of novel pluripotent stem cells only on DNA microarray gene
expression measurement
6. Epigenetic Profiles
Understanding the epigenetic landscape that is common to both systems
(iPSCs & ESCs) and connect it to gene regulation
- ChIP
- Genome-wide methylation
- Combining methylation mapping and gene expression signatures by
algorithm
7. The Scorecard Approach
An additional approach that combines gene expression and epigenetic
measures with an in vitro differentiation assay
- Comparison of DNA methylation and gene expression profiles with
reference standard hESC
- Testing each gene whether or not its DNA methylation and gene
expression levels fall within the range observed among ES cell lines
- Genes outside of this range are flagged
- The number and identity of these outlier genes are tracked for each iPSC
line
- The results of the outlier detection are summarized as a “deviation
scorecard”